Sanofi: all 2,424 studies
Page 16 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent ClaudicationCompletedNCT01157871Phase 2
- Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive DiseaseCompletedNCT01157156Phase 1
- Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned to Undergo Major AmputationCompletedNCT01157143Phase 1
- First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid TumorCompletedNCT01156870Phase 1
- A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid TumorsCompletedNCT01148615Phase 1
- Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1CompletedNCT01146678Phase 1
- Initiation and Titration of AmarylCompletedNCT01144728Phase 4
- Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver ImpairmentCompletedNCT01140607Phase 1
- Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial FibrillationCompletedNCT01140581Phase 4
- Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)CompletedNCT01138397Phase 3
- Retrospective Safety Survey In Patients Included In NV1FGF Clinical TrialsCompletedNCT01135797
- Canadian Outpatient VTE Management RegistryCompletedNCT01133002
- An Open-Label, Expanded Access Protocol of Iniparib Breast CancerNo longer availableNCT01130259
- Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy SubjectsCompletedNCT01129427Phase 1
- Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy SubjectsCompletedNCT01129414Phase 1
- Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy SubjectsCompletedNCT01129388Phase 1
- Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy SubjectsCompletedNCT01129375Phase 1
- Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis VaccinesCompletedNCT01129362
- Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy SubjectsCompletedNCT01129271Phase 1
- Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy SubjectsCompletedNCT01129063Phase 1
- Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 DiabetesCompletedNCT01127269Phase 4
- Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado TraditionalCompletedNCT01126606Phase 3
- Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic ImpairmentCompletedNCT01126086Phase 1
- Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy SubjectsCompletedNCT01123824Phase 1
- Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.CompletedNCT01122979Phase 4
- Randomized Study With Oxaliplatin in 2nd Line Pancreatic CancerCompletedNCT01121848Phase 3
- Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative StudyCompletedNCT01121835Phase 4
- Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)CompletedNCT01121822Phase 3
- Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal ImpairmentCompletedNCT01120314Phase 1
- Safety, Tolerability and Pharmacokinetics of SAR113945 Following Intra-articular Administration in Patients With Knee OsteoarthritisCompletedNCT01113333Phase 1
- A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based RegimenCompletedNCT01107756Phase 4
- Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control VaccineCompletedNCT01105559
- Sleep Satisfaction and Psychomotor Performance of AdultsCompletedNCT01097382Phase 4
- Elitek (Rasburicase) Immuno-Monitoring StudyTerminatedNCT01097369
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid TumorsCompletedNCT01095302Phase 1
- A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)CompletedNCT01090167Phase 1
- A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy AdultsCompletedNCT01089660Phase 2
- Oral Glutamine in the Prevention of Oxaliplatin-induced NeurotoxicityCompletedNCT01087658Phase 3
- Effect of Cabazitaxel on the QTc Interval in Cancer PatientsCompletedNCT01087021Phase 1
- SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung CancerCompletedNCT01086254Phase 2
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT01082549Phase 3
- Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast CancerCompletedNCT01082068Phase 1/2
- Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral NutritionTerminatedNCT01081938Phase 4
- Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use SettingTerminatedNCT01079364Phase 4
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive StrategyCompletedNCT01076764Phase 3
- Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) PatientsTerminatedNCT01076751
- Screening DIVA - Diffuse Vascular DiseaseCompletedNCT01076738
- Observatory on Elderly Patients "Les S.AGES"CompletedNCT01065909
- A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the PhilippinesCompletedNCT01064141Phase 2
- A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid TumorCompletedNCT01063946Phase 1
- Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid ArthritisCompletedNCT01063803Phase 2
- A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy InfantsCompletedNCT01062477Phase 3
- Ramipril 10 mg/Day PreventionCompletedNCT01053910Phase 4
- Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM)CompletedNCT01053728Phase 1/2
- Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in IndiaCompletedNCT01053143Phase 3
- Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)CompletedNCT01047566Phase 4
- Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast CancerCompletedNCT01045304Phase 2
- Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based RegimenCompletedNCT01042925Phase 1/2
- Tax First-line Chemotherapy With Different Doses and Then Maintenance TherapyCompletedNCT01038661Phase 3
- A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive DisorderCompletedNCT01034995Phase 2
- A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian CancerCompletedNCT01033292Phase 2
- A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian CancerCompletedNCT01033123Phase 2
- Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and AdultsCompletedNCT01032980
- Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of AgeCompletedNCT01031303Phase 4
- Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia ACompletedNCT01027377Phase 1
- Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)TerminatedNCT01026090Phase 4
- Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)CompletedNCT01024998Phase 1
- Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIACompletedNCT01024192Phase 4
- Artesunate Plus Amodiaquine in Malaria in Cote d'IvoireCompletedNCT01023399Phase 4
- A Study to Assess DV-601 in Subjects With Chronic Hepatitis BCompletedNCT01023230Phase 1
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid TumorsCompletedNCT01021150Phase 1
- Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) PatientsCompletedNCT01020383Phase 2
- Self Titration With Apidra to Reach Target Study (START)CompletedNCT01013571Phase 4
- Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial CarcinomaCompletedNCT01013324Phase 2
- START: Swiss Taxotere Alopecia Prevention TrialCompletedNCT01008774Not applicable
- Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid ArthritisCompletedNCT01007175Phase 1/2
- A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain)CompletedNCT00998543
- The RECORD Asia-Pacific Atrial Fibrillation RegistryCompletedNCT00995748
- Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration TrialCompletedNCT00995293Phase 3
- Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.CompletedNCT00994851Phase 3
- Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or DeathCompletedNCT00993382Phase 2
- A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)CompletedNCT00991133Phase 1
- Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00990054Phase 1
- Colorectal Cancer RECHALLENGEWithdrawnNCT00988897Phase 2
- Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum MalariaTerminatedNCT00988507Phase 2
- Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic SyndromesCompletedNCT00981240Phase 1
- Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus OmeprazoleCompletedNCT00971581Phase 3
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid TumorsCompletedNCT00968916Phase 1
- Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes PatientsCompletedNCT00965549Phase 4
- Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes MellitusCompletedNCT00964574Phase 4
- Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid ArthritisCompletedNCT00959036Phase 1/2
- Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg MonotherapyCompletedNCT00957554Phase 3
- Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes PatientsCompletedNCT00957060Phase 4
- Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg MonotherapyCompletedNCT00956644Phase 3
- A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 YearsCompletedNCT00956202Phase 2
- A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 MonthsCompletedNCT00956046Phase 2
- A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the ElderlyCompletedNCT00954798Phase 2
- Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep CWithdrawnNCT00951223
- Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary CareTerminatedNCT00950534Phase 4
- Irbesartan and Amlodipine Combination in Controlling Blood PressureCompletedNCT00950066Phase 2